Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 264 | 4,526 | 595 | 256 | 4,344 |
| Operating Income | -264 | -4,526 | -595 | -256 | -4,344 |
| Interest Expense | 394 | 972 | 607 | 1,095 | 298 |
| Other Income | 52 | 153 | 343 | 17,322 | -449 |
| Pre-tax Income | -606 | -5,344 | -859 | 15,971 | -5,090 |
| Net Income Continuous | -606 | -5,344 | -859 | 15,971 | -5,090 |
| Minority Interests | -81 | -55 | -82 | -41 | -241 |
| Net Income | $-525 | $-5,289 | $-778 | $16,012 | $-4,850 |
| EPS Basic Total Ops | 0.00 | -0.02 | 0.00 | 0.04 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | 0.04 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.02 | 0.00 | 0.04 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.02 | 0.00 | 0.04 | -0.01 |
| EBITDA(a) | $-98 | $1 | $-169 | $700 | $-4,155 |